192 related articles for article (PubMed ID: 29907642)
1. Telomerase reverse transcriptase coordinates with the epithelial-to-mesenchymal transition through a feedback loop to define properties of breast cancer stem cells.
El-Badawy A; Ghoneim NI; Nasr MA; Elkhenany H; Ahmed TA; Ahmed SM; El-Badri N
Biol Open; 2018 Jul; 7(7):. PubMed ID: 29907642
[TBL] [Abstract][Full Text] [Related]
2. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
[TBL] [Abstract][Full Text] [Related]
3. NMI inhibits cancer stem cell traits by downregulating hTERT in breast cancer.
Feng X; Xu X; Xiao X; Zou K; Yu W; Wu J; Tang R; Gao Y; Hao J; Zhao X; Liao Y; Chen Y; Huang W; Guo W; Kang L; Deng W
Cell Death Dis; 2017 May; 8(5):e2783. PubMed ID: 28492540
[TBL] [Abstract][Full Text] [Related]
4. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-mesenchymal transition and mesenchymal-epithelial transition are essential for the acquisition of stem cell properties in hTERT-immortalised oral epithelial cells.
Qiao B; Gopalan V; Chen Z; Smith RA; Tao Q; Lam AK
Biol Cell; 2012 Aug; 104(8):476-89. PubMed ID: 22548277
[TBL] [Abstract][Full Text] [Related]
6. Spheroid-Derived Cells From Renal Adenocarcinoma Have Low Telomerase Activity and High Stem-Like and Invasive Characteristics.
Saeednejad Zanjani L; Madjd Z; Rasti A; Asgari M; Abolhasani M; Tam KJ; Roudi R; Mælandsmo GM; Fodstad Ø; Andersson Y
Front Oncol; 2019; 9():1302. PubMed ID: 31921617
[TBL] [Abstract][Full Text] [Related]
7. The MyoD family inhibitor domain-containing protein enhances the chemoresistance of cancer stem cells in the epithelial state by increasing β-catenin activity.
Chen CJ; Yang CJ; Yang SF; Huang MS; Liu YP
Oncogene; 2020 Mar; 39(11):2377-2390. PubMed ID: 31911618
[TBL] [Abstract][Full Text] [Related]
8. BMI-1 activation is crucial in hTERT-induced epithelial-mesenchymal transition of oral epithelial cells.
Qiao B; Chen Z; Hu F; Tao Q; Lam AK
Exp Mol Pathol; 2013 Aug; 95(1):57-61. PubMed ID: 23712029
[TBL] [Abstract][Full Text] [Related]
9. Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity.
Bonuccelli G; Peiris-Pages M; Ozsvari B; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2017 Feb; 8(6):9868-9884. PubMed ID: 28039467
[TBL] [Abstract][Full Text] [Related]
10. hTERT promoter activity identifies osteosarcoma cells with increased EMT characteristics.
Yu L; Liu S; Guo W; Zhang C; Zhang B; Yan H; Wu Z
Oncol Lett; 2014 Jan; 7(1):239-244. PubMed ID: 24348856
[TBL] [Abstract][Full Text] [Related]
11. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.
Miki J; Furusato B; Li H; Gu Y; Takahashi H; Egawa S; Sesterhenn IA; McLeod DG; Srivastava S; Rhim JS
Cancer Res; 2007 Apr; 67(7):3153-61. PubMed ID: 17409422
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
13. Correlation between telomerase and mTOR pathway in cancer stem cells.
Dogan F; Biray Avci C
Gene; 2018 Jan; 641():235-239. PubMed ID: 29074462
[TBL] [Abstract][Full Text] [Related]
14. Human telomerase reverse transcriptase promotes the epithelial to mesenchymal transition in lung cancer cells by enhancing c-MET upregulation.
Prasad RR; Mishra DK; Kumar M; Yadava PK
Heliyon; 2022 Jan; 8(1):e08673. PubMed ID: 35024489
[TBL] [Abstract][Full Text] [Related]
15. Expression distribution of cancer stem cells, epithelial to mesenchymal transition, and telomerase activity in breast cancer and their association with clinicopathologic characteristics.
Makki J; Myint O; Wynn AA; Samsudin AT; John DV
Clin Med Insights Pathol; 2015; 8():1-16. PubMed ID: 25624778
[TBL] [Abstract][Full Text] [Related]
16. Communication Between Epithelial-Mesenchymal Plasticity and Cancer Stem Cells: New Insights Into Cancer Progression.
Zheng X; Dai F; Feng L; Zou H; Feng L; Xu M
Front Oncol; 2021; 11():617597. PubMed ID: 33968721
[TBL] [Abstract][Full Text] [Related]
17. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
18. Eribulin mesylate targets human telomerase reverse transcriptase in ovarian cancer cells.
Yamaguchi S; Maida Y; Yasukawa M; Kato T; Yoshida M; Masutomi K
PLoS One; 2014; 9(11):e112438. PubMed ID: 25375122
[TBL] [Abstract][Full Text] [Related]
19. Expression of human telomerase reverse transcriptase mediates the senescence of mesenchymal stem cells through the PI3K/AKT signaling pathway.
Zhao Q; Wang XY; Yu XX; Zhai YX; He X; Wu S; Shi YA
Int J Mol Med; 2015 Sep; 36(3):857-64. PubMed ID: 26178664
[TBL] [Abstract][Full Text] [Related]
20. A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling.
Bocci F; Jolly MK; George JT; Levine H; Onuchic JN
Oncotarget; 2018 Jul; 9(52):29906-29920. PubMed ID: 30042822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
